Topic List : Immunology
Allergies to COVID-19 vaccines mostly mild
In a study of mRNA-based COVID-19 vaccine doses given at Stanford Medicine, vaccine allergies were rare, mild and mostly triggered by a vaccine additive, not the mRNA.
Severe COVID-19, autoantibodies linked
A study spearheaded by Stanford researchers indicates that at least 1 in 5 hospitalized COVID-19 patients develops new antibodies that attack their own tissue within a week of admission.
COVID-19 symptoms and prior common colds
In COVID-19 patients whose symptoms were mild, Stanford researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses.
COVID-19 antibody treatment now available
An infusion of monoclonal antibodies can ease COVID-19 symptoms and reduce complications in recently diagnosed, non-hospitalized people at high risk. Now people can refer themselves.
Climate change lengthening allergy season
Air levels of pollen and mold spores in the San Francisco Bay Area are elevated for about two more months per year than in past decades, and higher temperatures are to blame, a Stanford Medicine study has found.
Promote vaccination, not herd immunity
Epidemiology expert Julie Parsonnet warns that COVID-19 vaccine hesitancy has probably made herd immunity unattainable, which makes vaccination all the more important for personal health.
Making medicine out of RNA
Ribonucleic acid, a key player in cellular protein production, is used, with increasing success, by biotechnologists bent on preventing and curing diseases.
Researchers on wildfires’ health impacts
California’s massive wildfires bring a host of health concerns. In a Q&A, Kari Nadeau and Mary Prunicki of the Sean N. Parker Center for Allergy and Asthma Research at Stanford discuss the threats posed by air pollution from the fires.
Immune deviations seen in severe COVID-19 cases
A Stanford study shows that in severely ill COVID-19 patients, “first-responder” immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.
$1.49 million for inflammation research
The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.